Roger Michael Gendreau's most recent trade in Dogwood Therapeutics Inc. was a trade of 82,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dogwood Therapeutics Inc | Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 82,500 | 82,500 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc | Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2025 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc | Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 12,075 | 12,075 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc | Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 88,085 | 88,085 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc | Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc | Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) |